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   An attempt was made ’to search the mechan’ism underlying the beneficial effect of blood
trqnsfusion effects usipg the rat renal transplantation model．
   The mean’surviy． al tim．．e ．of （Sprague－Dawley （SD x Wistar）） Fi renal grqfts in yntreated
SD． re．cipient＄ was 11．3 days， Treatment to SD recipients with 1 ml of Wistar whole blood．
7 t．Q 21，da．Ys． pr．ior td transplantatiori’Prolbnged the mean survival time of （SD x Wistar） Ft
renal．grafts and maximuin e．fl． ect ’Qf prolQngatio．n （＞81．3 days） was seen when renal trans－
piantation was performed on the． 9th day after the treatment． Treatment with Wistar bone
marrow cells， red blood cells and platelets 9 days before transplantation prolonged the mean
survival time to ＞41．0 days， ＞39．3 days and ＞46，9 days， respectivelY， whereas no significant
effect was observed．in the SD recipients pretreated with Wistar thymocytes or with Wistar
plasma． Third party blood transfusion also had moderate effects on the prolongatiop of
renal graft survival， but maximum effect．s of blood trans．fusion were obtained by donor specific
blood transfusion．
   Sera taken from SD rats at various times after the treatment with Wistar whole blood
were assayed’@for their abilitY to suppress the mixed leukocyte reaction （MLR） of SD res－
ponder and（SD x Wistar）FI stimUlator cclls． S叩pressor activity rapidly increased With
tinie yp’tQ 7 d4．ys after blood trarisfusion． Potent suPpression of the MLR was observed
with sera． ．obt，ained．between 7 and 15． days after the treatment． Thereafter， suppressor acti－
vity gradually decreased but sera obtained even 21 days after the treatment still suppressed
the MLR by more than 50％．
   The experimental results suggest that MLR suppressor factor（s） generated in the reci－
pients by blood transfusion may play an important role in preventing renal ，graft re，jection．
Furthermore． not only class II antigens but also class 1 antigens in the transfusate ’may be
relevant to the immune response which causes a beneficial effect by pretransplant blOod
transfusion．
Key words： Rat renal transplantation， Pretransplant blood transfusion， Mixed leukocyte reaction
            （MLR）
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Ethilon black nylon．iEthicon Inc．），静脈の吻合
には7．O Mersilk（Ethicon Inc．）を使用した．尿路











 （1）Wistarラットめ全血 （I ml）
 （2）Wistarラットの骨髄リンパ球 （4xlO6，全血
      1ml中に含まれる白血球数に相当する）
 （3）Wistarラットの胸腺リンパ球 （4×106）
 （4）Wistarラットの赤血球  （4 × 109＞
 （5）Wistarラットの血小板 （2×109）
 （6）Wistarラットの血漿 （0．5 ml）






















































9200，Dynatech Co．）を使用してone way MLR．
をおこなった．responder cellと stimulator cell
の細胞数は，それぞれ1×106／we11ずっとし，培養液
：量は300μ1／we11とした．培養液としてはRPM116
40（Grand Island Biological Co．）100 ml中に
HEPE 25 mM， NaHCO3 200 mg， 2－mercapto－











ル， P－po， popQp， nonionic surfactant in xylene
半井化学薬品㈱）を3ml加え，液体シンチレーショ
ンカウンター（TRI－CARB 300C Liquid Scintilla．

























泌尿紀要 31巻 12号 1985年
Survival of （SDxWistar） Fi renal grafts－in SD rats pretreated，with Wistar whole
blood at different’days before transplantationa
Treatrnent of SD爬cipieats（SD・Wi・t…）F、爬nal L・・r・・ft・v・viva！（d・y・）bMean survival Fraction．or rats  days surviveci＞30 diay＄
Noロe
           Wist鐘r whole blood（1ml），
days before transpianしation
     od
     三
     3
     5
     7
     9
    M
    21
11， 11， 11， 13， 13
8， 10賢 15， 工5， 18
6， 11， 13， 13， 20
12， 12， 16， 16， 21
11， 11， 14， 16， 19， 21
18， 23， 31， 35， ＞IOO， ＞100，
13， 75， ＞100， ＞100， ＞iOO， ＞100，
9， 14， 37， ＞100， ＞IOO，



















a：川recゆients were bi｝ateraily n巳phrectomized irnmediate］y after the compleLion of renal transplantation．
b： Graft survival was assessed by Tecipient surVival．
c： One ml of Wistar whole blood was．injected ；．v． into the penile vein of SD Tecipients at specified days before
 transplantation．
d： Treatment was done at the time of transplantation．
Table 2．Survival of （SDxWistar） Fi renal grafts in
immunogens from Wistar ratsE
SD rats pretreated with various
Treatrnent of SD recipients（SDXWistar） Fi tenaL graft ＄urvival （days）bMean survival Fraction of rats
  days survived＞30days
Saline （lmi）
Wistar whole blood （lml）
Wistar bone rnarrow cells （4x106）C
WIstar thymocytes （4xlO6）e
Wis｛ar red blood cells （4xlOg）e
Wistar pZatetets （2×10S）C
Wistar ptasma （o．srnDd
且1， 互3酔 13， 14， 14，
13， 7s， ＞leo， ＞loo， ＞loo， ＞loo，
！O， 29， 30， 33， 44， ＞100，
7， Z3， 16， 16， 21， 24，
11， 17， 29， 33， 41， 44， ＞IOe，
8， 15， 28， 34， 43， ＞100， ＞100，















a1 Rena：L transplantation with，biiaLeral nephrectomy was performed on the 9 th day after pretreatrnent．
bl Graft survival was assessed by recipient survivat．
c： Ce］1 sllspension was rmade in 1 ml of saline．
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Inhibition of the MLR by sera from SD rats pretreated with Wistar
whole blood
Responder S timulater added concentration （3H）thymidine
’cellsa cellsb sera of sera （vuVwell）C incorporation （mean eptn ±SD）
Percent




















































































a： IXIO6 spleen cells from no：rnal SD rats per wetl were used as responder cel｝s．
b： IXIO6 1）Tnphnode cells from normal SD or （SDXNVist．ar） Fi ra ts per we！1 were
 uged as stimulator cells．
c：Total volume of culture rnedittrn was 300♂μレ「veiL
・・一一醐・ s1－1器遷ii課ll器回り・1・・
e： Norrnal SD sera．





















































   舳鴨軸、      、o賢魅          、鴨隔              つ
24 48 72 96 120 韮44  hourS
Fig． 1．Kineticsi of the MLR of SD responder and （SDxWistar） Fi
stimulator cells after the addition of sera froin normal or’
pretreatad SD rats． Cultures were harvested daily after
18Lhr pulse with （3H）一thymidine．
Figure 1 illustrates the incorporated radieactivity （cpm） of
parallel cultures by adding 8 rd per well of normal SD sera
（e－e）’or sera from SD rats 9 days after the treatment
















Fig． 2． Appearance and persistence of suppression of the MLR ’by SD
        ser．a after treatment with Wistar whole blood．
        SD rcsponder and （SDxWistar） Fi stimulator cells were cultured
        with normal SD sera ot sera taken from SD rats various days
        after allogeneic blood transfusion at a concentration of 8 pt1 per
        well． Cultures were pulsed with （3H）一thymidine after 96 hr of
        incubation． Pe’rcent suppressiori was calculated by the formu14
・ ’ described in Materials and Methods：・
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